Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China

Patients with NLSDM display clinical heterogeneities despite sharing the same mutation (c.757 + 1G > T) of the PNPLA2 gene, may suggest a founder effect in the region.